Asaf Danziger, Chief Executive Officer at NovoCure Ltd (NVCR), sold 103,000 shares at $95.00 ($9.8M) on 2019-11-25, disclosed to the SEC on 2019-11-26.
Open-market sale of $9.8M NVCR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2021-04-15 | $38.5M | — | Filing → |
| NVCR | SELL | 2020-12-22 | $61.4M | — | Filing → |
| NVCR | SELL | 2020-09-17 | $10.2M | — | Filing → |